DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Younossi ZM, Stepanova M, Feld J. , et al.
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: results from ASTRAL-1 placebo-controlled trial.
J Hepatol 2016;
65 (01) 33-39
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.